NCT01259674已完成3 期
Randomized, Single-center, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Tolerability of ABO/MEG-B-09 in Pediatric Cough
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 102
- 试验地点
- 2
- 主要终点
- Cough score variation
研究概览
简要总结
The present clinical trial will examine the use of ABO/MEG-B-09 syrup in children with acute cough as compared to a placebo syrup.
详细描述
Subjects will be asked to take 4 doses of 5 ml containing a mixture of honey and other natural ingredients or a placebo syrup everyday, during 8 days. The following outcomes will be noted down in a diary: occurence and severity of diurnal and nocturnal cough events (cough score) and symptoms, impediment of normal life activities (school, sleeping), the number of medical visits and type of medication needed if any.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 3 Years 至 6 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children aged between 3 and 6
- •Acute cough - lasting 1-3 weeks
- •Written informed consent by the parents/legal tutors
- •Parents/legal tutors must be willing not to give to the child other medications or products for the treatment of cough during the study period, unless they become clinically indicated in which case a rescue regimen can be administered and the child will be withdrawn from the study
- •Parents/legal tutors must be willing to comply with the study protocol
排除标准
- •Children treated with immunostimulators and immune regulating drugs during the last month before starting the study
- •Children with immunodeficiencies or immune suppression
- •Children with chronic diseases - Pulmonary Diseases, Renal insufficiency, Heart diseases
- •Children treated with antibiotics, including prophylactic treatment
- •Children being treated with systemic corticosteroids - including oral aerosol inhaler
- •Children with potential immunosuppressive viral diseases - Measles, Chickenpox, Rubella, Infectious mononucleosis - within the last month
- •Children who have participated in previous studies with experimental products within the last month
- •Children with asthma or suspected diagnosis of asthma
- •Children with bacterial diseases - Pneumonia, Sepsis
- •Children with diabetes because of the high content of sugar of the study products - ABO/MEG-B-09 and placebo
- •Children allergic to any study product ingredients
- •Children/Parents/legal tutors with psychological condition that may, in the investigator's opinion, adversely affect their co-operation with the study protocol - syrup administration or compilation of the diary
结局指标
主要结局
Cough score variation
时间窗: Measured at Baseline Visit (day 0) and at the Last Visit (day 8)
Clinical diurnal and nocturnal cough score (Chung)
次要结局
- Cough reflex sensitivity(Measured at Baseline Visit (day 0) and at the Last Visit (day 8))
- The ventilation of the various pulmonary zones(Measured at Baseline Visit (day 0) and at the Last Visit (day 8))
- Quality of life(Measured at Baseline Visit (day 0) and at the Last Visit (day 8))
- Objective breath sounds(Measured at Baseline Visit (day 0) and at the Last Visit (day 8))
研究者
研究点 (2)
Loading locations...
相似试验
招募中
4 期
The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis PatientsAcute BronchitisNCT06411925SamA Pharmaceutical Co., Ltd296
已完成
2 期
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)Attention-Deficit/Hyperactivity DisorderNCT00528697AbbVie (prior sponsor, Abbott)278
已完成
2 期
Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)Attention-Deficit/Hyperactivity DisorderNCT00640419AbbVie (prior sponsor, Abbott)121
终止
2 期
Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's DiseaseAlzheimer's DiseaseNCT00555204Abbott337
Unknown
4 期
Laryngeal Nerve Block for Chronic CoughLaryngeal Nerve BlockChronic Neurogenic CoughLaryngeal HypersensitivityNCT05292677Eastern Virginia Medical School40